stake sports betting app
stake betting app
-
FDA approves blood diluted drug BRILINTA for acute coronary syndrome
2011-07-26
Business Club, July 26th News July 20，The US Food and Drug Administration (FDA) approves blood dilution drug BriLinta to reduce cardiovascular death and heart disease seizures of patients with acute coronary syndrome (ACS) patients。 ACS includes a variety of diseases that cause a series of symptoms，If an unstable angina pectoris or heart disease attack，It can be triggered due to reduced heart blood flow。brilinta By preventing the formation of new blood clots，to keep blood flowing in the body，Help reduce the My stake betting apprisk stake sports betting appof other cardiovascular events。 Already on brilin ...
- 2011-07-26my country's one -type compound is recognized by CAS "60 million kinds of substances"
- 2011-07-26xarelto is allowed to prevent thrombosis of patients with knee joints
- 2011-07-25The operation of the pharmaceutical industry is generally the first
- 2011-07-21The world's largest pharmaceutical giant is facing spin -off
- 2011-07-19Fortune 500 list of Chinese corporate wealth is released. Fifteen pharmaceutical companies are shortlisted
- 2011-07-15The first China Pharmaceutical Capital Annual Conference will be held at the Optics Valley of Wuhan at the end of July
- 2011-07-15Drugs of review, speed up and innovative drugs accelerate
- 2011-07-13Deputy Director of Food and Drug Administration: stake betting appDo a Stake Sports Bettinggood job of basic medicine supervision is the focus of work in the second half of the year
- 2011-07-11The Fifth National Pharmacy Expo opened the Pharmaceutical Hunan Army Group for attack
